Evidence map›Paper›PMID 26221763›Full record

ReviewVirus research2016

The emerging role of long non-coding RNAs in HIV infection.

Daniel C Lazar, Kevin V Morris, Sheena M Saayman

Open access · greenAbstract readReview
In one paragraph

Review in Virus research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. LncRNAs in the Type I Interferon Antiviral Response.International journal of molecular sciences · 2020
    Review
  12. Article
  13. The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Daniel C LazarDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA. Electronic address: dlazar@scripps.edu.
Kevin V MorrisDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA; School of Biotechnology and Biomedical Sciences, University of New South Wales, Kensington, NSW, Australia. Electronic address: kmorris@scripps.edu.
Sheena M SaaymanDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA. Electronic address: sheena@scripps.edu.
Scripps Research Institute · US

Funding

Targeted Delivery Vechicles for OligonucleotidesP01AI099783 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AKKINA, RAMESH · 2012 to 2016
$7.4M
Targeted inhibition of HIV-1 latencyR01AI111139 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2014 to 2018
$2.7M
Activating cystic fibrosis transmembrane conductance regulator: the therapeutic potential of RNA directed gene activationR01DK104681 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2015 to 2019
$1.9M
Activation of silenced tumor suppressor genes by non-coding RNAR01CA151574 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI VOGT, PETER K · 2010 to 2014
$1.9M
The Antisense Transcriptome and the Epigenetics of Cancer.R01CA153124 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI VOGT, PETER K · 2010 to 2013
$1.2M
Non-coding RNAs involved in HIV-1 LatencyR01AI084406 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2009 to 2010
$889k
NCI NIH HHS NCI R01CA151574NCI NIH HHS NIH R01 CA153124NCI NIH HHS R01 CA151574NCI NIH HHS R01 CA153124NIAID NIH HHS P01 AI099783NIAID NIH HHS R01 AI084406NIAID NIH HHS R01 AI111139NIDDK NIH HHS R01 DK104681NIDDK NIH HHS R01 DK104681-01PHS HHS NIAID P01 AI099783-01
6 · The paper itself

Abstract

The discovery of long non-coding RNAs (lncRNAs) and the elucidation of the mechanisms by which they affect different disease states are providing researchers with a better understanding of a wide array of disease pathways. Moreover, lncRNAs are presenting themselves as both unique diagnostic biomarkers as well as novel targets against which to develop new therapeutics. Here we will explore the intricate network of non-coding RNAs associated with infection by the human immunodeficiency virus (HIV). Non-coding RNAs derived from both the human host as well as those from HIV itself are emerging as important regulatory elements. We discuss here the various mechanisms through which both small and long non-coding RNAs impact viral replication, pathogenesis and disease progression. Given the lack of an effective vaccine or cure for HIV and the scale of the current pandemic, a deeper understanding of the complex interplay between non-coding RNAs and HIV will support the development of innovative strategies for the treatment of HIV/acquired immunodeficiency disease (AIDS).

Indexed as

AnimalsHIV-1HIV InfectionsHost-Pathogen InteractionsHumansRNA, Long NoncodingRNA, ViralRNA, Long NoncodingRNA, ViralEpigeneticHIVlncRNAmiRNATranscription

Identifiers

PMID26221763
PMCPMC4728059
OpenAlexW1417481847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.